Candel Therapeutics, Inc. (CADL)

NGM – Real Time Price. Currency in USD

10.77

+0.12 (1.13%)

Market open: Aug 12, 2026, 11:13 AM EDT

10.65

-0.00 (-0.01%)

Previous after-hours: Aug 11, 2026, 7:41 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

125K

Cost of goods sold

-845K

-990K

-1M

-987K

Gross Profit

-845K

-990K

-1M

-862K

Operating expenses (excl. COGS)

-47M

-32M

-37M

-34M

Operating Income

-48M

-33M

-38M

-35M

Non-operating income, total

10M

-22M

452K

16M

Pretax income

-38M

-55M

-38M

-19M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-38M

-55M

-38M

-19M

Discontinued operations

Net income

-38M

-55M

-38M

-19M

Dilution adjustment

Preferred dividends

Candel Therapeutics, Inc. (CADL)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Candel Therapeutics, Inc. (CADL)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Candel Therapeutics, Inc. (CADL)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Candel Therapeutics, Inc. (CADL)

Income Statement (Annual)

Income Statement (Annual)